From: Real-world use of difelikefalin in hemodialysis patients at a large dialysis organization in the United States: a retrospective database study
All Patients
(N = 156)
CRG
(N = 84)
IRG
(N = 72)
P-Value
(CRG vs. IRG)
WI-NRS decrease by 1+ (%)
68
80
54
0.0006
WI-NRS decrease by 3+ (%)
46
56
35
0.0080
WI-NRS decrease by 4+ (%)
42
48
0.1034